- Home
- BLRX vs GENK Comparison
BLRX vs GENK Comparison
Compare BLRX & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- GENK
- Stock Information
- Founded
- BLRX 2003
- GENK 2011
- Country
- BLRX Israel
- GENK United States
- Employees
- BLRX N/A
- GENK N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- BLRX Health Care
- GENK Consumer Discretionary
- Exchange
- BLRX Nasdaq
- GENK Nasdaq
- Market Cap
- BLRX 36.0M
- GENK 41.1M
- IPO Year
- BLRX 2011
- GENK 2023
- Fundamental
- Price
- BLRX $0.48
- GENK $8.29
- Analyst Decision
- BLRX Strong Buy
- GENK Strong Buy
- Analyst Count
- BLRX 2
- GENK 3
- Target Price
- BLRX $11.50
- GENK $13.17
- AVG Volume (30 Days)
- BLRX 407.5K
- GENK 58.5K
- Earning Date
- BLRX 11-29-2024
- GENK 11-12-2024
- Dividend Yield
- BLRX N/A
- GENK N/A
- EPS Growth
- BLRX N/A
- GENK N/A
- EPS
- BLRX N/A
- GENK N/A
- Revenue
- BLRX $17,048,000.00
- GENK $198,834,000.00
- Revenue This Year
- BLRX N/A
- GENK $15.09
- Revenue Next Year
- BLRX N/A
- GENK $20.04
- P/E Ratio
- BLRX N/A
- GENK N/A
- Revenue Growth
- BLRX N/A
- GENK 12.50
- 52 Week Low
- BLRX $0.39
- GENK $5.61
- 52 Week High
- BLRX $1.93
- GENK $14.46
- Technical
- Relative Strength Index (RSI)
- BLRX 53.32
- GENK 43.52
- Support Level
- BLRX $0.40
- GENK $7.62
- Resistance Level
- BLRX $0.46
- GENK $10.33
- Average True Range (ATR)
- BLRX 0.03
- GENK 0.58
- MACD
- BLRX 0.01
- GENK -0.11
- Stochastic Oscillator
- BLRX 94.50
- GENK 24.72
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc is an Asian casual dining restaurant in the United States. It offers an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables.